RxDoctor Payments Data

James Clancy

Foot & Ankle Surgery · Atlantis, FLNPI 1346294576

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $76,267 of the $97,073 with a category attached, or 78.6%. Paragon 28, Inc. accounts for 81.5% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2021 at $24,757 and has fallen 89.3% since, to $2,656 in 2025. Among foot & ankle surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$97,073in general payments, 2019–2025

Across 241 payments — averaging $402.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$79K
  • Stryker$12K
  • Flower Orthopedics Coporation$2K
  • Arthrex$1K
  • Integra Lifesciences Corporation$562
  • Treace Medical Concepts, Inc.$470
  • plus $2K from 16 others
$22,748in research payments, 2019–2025

Across 17 payments — averaging $1338.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Paragon 28, Inc.$23K

What the payments were for

  • Royalty or licence$76,26779%
  • Consulting fees$1,5082%
  • Travel & lodging$7,0507%
  • Food & beverage$10,74411%
  • Education$1,1511%
  • Gifts$3530%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$97,073 in reported general payments places this provider in the 95th percentile of 850 foot & ankle surgery providers in Florida.

See all foot & ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$638,882
Medicare patients
364
Services billed
2,497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban29$11,219
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen55$561
Ondansetron OdtOndansetron53$552
Cephalexin22$278
Gabapentin17$148
Methylprednisolone19$127
Meloxicam54$70

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Atlantis

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →